English  |  正體中文  |  简体中文  |  Items with full text/Total items : 16812/19099 (88%)
Visitors : 6427479      Online Users : 60
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/31618


    標題: Hyperbaric Oxygen Therapy Is Associated With Lower Short- and Long-Term Mortality in Patients With Carbon Monoxide Poisoning
    作者: Huang, Chien-Cheng
    Ho, Chung-Han
    Chen, Yi-Chen
    Lin, Hung-Jung
    Hsu, Chien-Chin
    Wang, Jhi-Joung
    Su, Shih-Bin
    Guo, How-Ran
    貢獻者: Chi Mei Med Ctr, Dept Emergency Med
    Chi Mei Med Ctr, Dept Geriatr & Gerontol
    Chi Mei Med Ctr, Dept Occupat Med
    Chi Mei Med Ctr, Dept Med Res
    Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth
    Southern Taiwan Univ Sci & Technol, Bachelor Program Senior Serv
    Southern Taiwan Univ Sci & Technol, Dept Biotechnol
    Southern Taiwan Univ Sci & Technol, Dept Leisure Recreat & Tourism Management
    Chia Nan Univ Pharm & Sci, Dept Pharm
    Taipei Med Univ, Dept Emergency Med
    Natl Cheng Kung Univ Hosp, Dept Occupat & Environm Med
    關鍵字: carbon monoxide poisoning
    hyperbaric oxygen therapy
    mortality
    日期: 2017-11
    上傳時間: 2018-11-30 15:50:26 (UTC+8)
    出版者: Elsevier Science Bv
    摘要: BACKGROUND: To date, there has been no consensus about the effect of hyperbaric oxygen therapy (HBOT) on the mortality of patients with carbon monoxide poisoning (COP). This retrospective nationwide population-based cohort study from Taiwan was conducted to clarify this issue. METHODS: Using the Nationwide Poisoning Database, we identified 25,737 patients with COP diagnosed between 1999 and 2012, including 7,278 patients who received HBOT and 18,459 patients who did not. The mortality risks of the two cohorts were compared, including overall mortality, and stratified analyses by age, sex, underlying comorbidities, monthly income, suicide attempt, drug poisoning, acute respiratory failure, and follow-up until 2013 were conducted. We also tried to identify independent mortality predictors and evaluated their effects. RESULTS: Patients who received HBOT had a lower mortality rate compared with patients who did not (adjusted hazard ratio [AHR], 0.74; 95% CI, 0.67-0.81) after adjusting for age, sex, underlying comorbidities, monthly income, and concomitant conditions, especially in patients younger than 20 years (AHR, 0.45; 95% CI, 0.26-0.80) and those with acute respiratory failure (AHR, 0.43; 95% CI, 0.35-0.53). The lower mortality rate was noted for a period of 4 years after treatment of the COP. Patients who received two or more sessions of HBOT had a lower mortality rate than did those who received HBOT only once. Older age, male sex, low monthly income, diabetes, malignancy, stroke, alcoholism, mental disorders, suicide attempts, and acute respiratory failure were also independent mortality predictors. CONCLUSIONS: HBOT was associated with a lower mortality rate in patients with COP, especially in those who were younger than 20 years and those with acute respiratory failure. The results provide important references for decision-making in the treatment of COP.
    關聯: Chest, v.152, n.5, pp.943-953
    Appears in Collections:[藥學系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML24View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback